4//SEC Filing
Young Rodney KB 4
Accession 0001415889-24-027011
CIK 0001673772other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 8:00 PM ET
Size
26.9 KB
Accession
0001415889-24-027011
Insider Transaction Report
Form 4
Young Rodney KB
CHIEF FINANCIAL OFFICER
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−140,000→ 0 totalExercise: $21.73Exp: 2029-12-01→ Common Stock (140,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+140,000→ 140,000 totalExercise: $1.57Exp: 2029-12-01→ Common Stock (140,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−60,000→ 0 totalExercise: $19.53Exp: 2031-01-27→ Common Stock (60,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+60,000→ 60,000 totalExercise: $1.57Exp: 2031-01-27→ Common Stock (60,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−65,000→ 0 totalExercise: $19.86Exp: 2032-01-27→ Common Stock (65,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+68,000→ 68,000 totalExercise: $1.57Exp: 2033-01-30→ Common Stock (68,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−90,000→ 0 totalExercise: $24.75Exp: 2034-01-30→ Common Stock (90,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+90,000→ 90,000 totalExercise: $1.57Exp: 2034-01-30→ Common Stock (90,000 underlying) - Award
Employee Stock Option (right to buy)
2024-11-13+65,000→ 65,000 totalExercise: $1.57Exp: 2032-01-27→ Common Stock (65,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2024-11-13−68,000→ 0 totalExercise: $29.05Exp: 2033-01-30→ Common Stock (68,000 underlying)
Footnotes (9)
- [F1]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 2, 2019 and is fully vested.
- [F2]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2021.
- [F3]1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2021.
- [F4]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2022.
- [F5]1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2022.
- [F6]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 31, 2023.
- [F7]1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of January 1, 2023.
- [F8]The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 31, 2024.
- [F9]1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of January 1, 2024.
Documents
Issuer
RAPT Therapeutics, Inc.
CIK 0001673772
Entity typeother
Related Parties
1- filerCIK 0001337831
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 8:00 PM ET
- Size
- 26.9 KB